A novel artificial intelligence system is offering renewed hope for individuals living with Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that often leads to complete paralysis, including the loss of speech. Developed through a unique partnership between the Kyutai laboratory and ALS patient-turned-entrepreneur Olivier Goy,the open-source AI tool-dubbed “Invincible Voice“-aims to restore a patient’s ability to communicate using their own voice and intonation. The system, launched January 20, 2026, represents a major stride in assistive technology and underscores the growing potential of AI to address critical healthcare challenges.
A new artificial intelligence system offers a potential lifeline for individuals with Amyotrophic Lateral Sclerosis (ALS), also known as Charcot disease, restoring their ability to communicate. Developed by the laboratory Kyutai in collaboration with entrepreneur Olivier Goy, who himself lives with ALS, the AI – dubbed “Invincible Voice” – is now available as an open-source tool.
Restoring Voice and Intonation
The technology leverages real-time speech transcription and synthesis models created by Kyutai, and incorporates an integrated language model to suggest responses. Crucially, Invincible Voice can recreate a patient’s unique voice and intonation using just 10 seconds of previously recorded speech. The system is also compatible with eye-tracking devices, offering an alternative input method for those with limited mobility. While the system demonstrates promise, developers acknowledge a “rather significant” latency remains.
“Invincible Voice helps a person who has lost the ability to speak to remain in the conversation,” explains Olivier Goy. “You are spoken to, the tool proposes a possible response, you validate it, modify it, or reject it, and it is expressed… with your voice.” He emphasizes the collaborative nature of the project, stating, “Kyutai brought the scientific excellence. I brought the lived experience of a patient.”
ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and ultimately, loss of speech. Finding ways to maintain communication is a critical aspect of care for those living with the condition, and this technology represents a significant step forward.
Prioritizing Public Benefit
“What we have developed with Kyutai demonstrates that science, when guided by the common good, can restore connection, autonomy, and dignity,” Goy said.
By making the technology freely accessible, the developers hope to encourage further innovation. “This should allow developers, engineers, researchers, companies designing improved and alternative communication systems (AAC), or healthcare organizations to improve the prototype or adapt it to other pathologies (aphasia, neurodegenerative diseases).” Kyutai is currently seeking a medical startup and industrial partners to develop a widely available application.
Currently, approximately 450,000 people worldwide are affected by ALS.
Sources: Les Echos, Marion Simon-Rainaud (January 20, 2026); Olivier Goy on Instagram (January 20, 2026); France info (January 21, 2026)
